Advances in Pain Management 2016
Saturday, April 9, 2016
7:00am - 3:30pm
University of Rochester School of Medicine & Dentistry
415 Elmwood Avenue
Rochester, NY 14618
Chronic pain has a devastating impact on the lives of over one hundred million U.S. adults --more than the number affected by heart disease, diabetes, and cancer combined (Tsang, Von Korff et al. 2008, Dzau and Pizzo 2014). Pain is the second most common reason to seek outpatient treatment from primary care physicians and accounts for a fifth of emergency room visits. The distinction between acute and chronic pain is often overlooked in clinical practice leading to: 1) poor assessment; 2) inadequate patient and caregiver education about treatment; and 3) increased risk of adverse events related to analgesic medications including opioids. The annual national economic cost associated with chronic pain is estimated to be $560–635 billion (2011). To make matters more complex, the United States is currently confronting twin epidemics of chronic pain and prescription drug abuse. This course explores assessment, treatment, and management options to help physicians tailor individualized care plans for patients with acute and chronic pain. The program also aims to help clinicians manage population risks associated with managing analgesics. Presentations by leading international clinical and scientific experts will examine the evidence for new diagnostic tools for chronic pain, the analgesic benefit for different therapeutic classes ranging from oral to intrathecal agents to neuromodulation, the neurobiology of chronic pain and migraine, and the evidence for using these therapies in clinical practice. The role of nonpharmacologic therapies in the management of pain will also be examined. This recurring educational program and the live event’s affiliated website, evidencebasedpain.org, prompted the American Pain Society’s recognition of the program sponsor as one of only two Centers of Excellence in Pain Medicine nationwide in 2013.
At the conclusion of this activity, participants will be better able to:
- Coordinate a multidisciplinary team approach to the management of acute, chronic, and cancer pain syndromes
- Apply standardized protocols for the assessment of acute and chronic pain
- Explain the role of novel analgesics including anti-CGRP antibody therapy, anti-NGF antibody therapy, buprenorphine products, abuse deterrent opioid formulations, novel NSAID formulations, and new topical analgesics
- Optimize patient selection criteria for treatments and patient safety protocols to mitigate the risks of analgesic therapy
- Implement the use of evidence-based, patient-centered care in the primary care setting
- Reduce the public health burden of misuse, abuse, and diversion of opioid medication through better screening and monitoring of patients prescribed opioid therapy
Please contact the Center for Experiential Learning 585-275-7666 with any questions or concerns or require assistance with online registration.
Online Registration Available Here